NDC 10019-929-60 - IFOSFAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10019-929
- Requested NDC
- 10019-929-60
- Package NDCs from labels
- 10019-929-60, 10019-929-03
- Manufacturer
- Baxter Healthcare Company | Baxter Deutschland GmbH
- Effective date
- 2024-12-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IFOSFAMIDE - Baxter Healthcare Company | Baxter Deutschland GmbH | Baxter Healthcare Company | Baxter Deutschland GmbH | 2024-12-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10019-929-03 | IFOSFAMIDE | 1 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 1 | 11 | |
| 10019-929-60 | IFOSFAMIDE | 60 mL in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 60 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10019-929-03 | EA - Each | 10019-929 | 7045d250-4a05-49d8-a19d-2da232efbe1a | 1 | 2019-02-13 |
| 10019-929-60 | EA - Each | 10019-929 | 625ff536-80c1-462d-bca8-42eb1ae99bd9 | 1 | 2019-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ifosfamide | IFOSFAMIDE FOR INJECTION | SteriMax Inc. | 98798c5e-8384-4990-a1b5-60dfb1e667bb | 2026-09-01 | 1791593 UM20QQM95Y | |
| Ifosfamide | IFOSFAMIDE | Fresenius Kabi USA, LLC | a311a947-7b78-4226-bfe0-f4aa0be20e27 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 1791593 UM20QQM95Y |
| IFEX | IFOSFAMIDE | Baxter Healthcare Corporation | b7241707-7538-4d1a-91e7-3a25a91e0b9a | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | NDA019763 1791588 1791593 UM20QQM95Y |
| IFOSFAMIDE | IFOSFAMIDE | Baxter Healthcare Company | 91e433a9-6800-43a6-ac13-a49a04a5aecd | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | NDA019763 1791588 1791593 UM20QQM95Y |
| IFOSFAMIDE | IFOSFAMIDE | Baxter Healthcare Company | efb1d03b-2d91-406e-8110-d3a58b8fa7cc | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | NDA019763 10019-929-03 10019-927-20 10019-927-01 10019-929-60 10019-927 10019-929 10019092960 1791588 1791593 df9e4e92-2910-4268-9d98-44ab1fd6e47e efb1d03b-2d91-406e-8110-d3a58b8fa7cc UM20QQM95Y |
| Ifosfamide | IFOSFAMIDE | Hikma Pharmaceuticals USA Inc. | c90ab05f-8fe5-437e-a1c0-8b11ef63291e | 2020-06-01 | Boxed warning, Warnings, Adverse reactions | UM20QQM95Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.